1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global RNA Therapy Clinical Trials Market
2.2. Global RNA Therapy Clinical Trials Market, By Modality, 2023 (US$ Million)
2.3. Global RNA Therapy Clinical Trials Market, By Clinical Trials Phase, 2023 (US$ Million)
2.4. Global RNA Therapy Clinical Trials Market, By Therapeutic Areas, 2023 (US$ Million)
2.5. Global RNA Therapy Clinical Trials Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. RNA Therapy Clinical Trials Market: Competitive Analysis
3.1. Market Positioning of Key RNA Therapy Clinical Trials Market Vendors
3.2. Strategies Adopted by RNA Therapy Clinical Trials Market Vendors
3.3. Key Industry Strategies
4. RNA Therapy Clinical Trials Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global RNA Therapy Clinical Trials Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. RNA interference
5.3.2. Antisense therapy
5.3.3. Messenger RNA
5.3.4. Oligonucleotide, non-antisense, non-RNAi

6. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Phase I
6.3.2. Phase II
6.3.3. Phase III
6.3.4. Phase IV

7. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Rare Diseases
7.3.2. Anti-infective
7.3.3. Anticancer
7.3.4. Neurological
7.3.5. Alimentary/Metabolic
7.3.6. Musculoskeletal
7.3.7. Cardiovascular Respiratory
7.3.8. Sensory
7.3.9. Others


8. North America RNA Therapy Clinical Trials Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
8.3. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
8.4. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.5.RNA Therapy Clinical Trials Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
8.5.1.1.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
8.5.1.1.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
8.5.1.2.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
8.5.1.2.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
8.5.1.3.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
8.5.1.3.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)

9. UK and European Union RNA Therapy Clinical Trials Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
9.3. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
9.4. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.5.RNA Therapy Clinical Trials Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
9.5.1.1.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
9.5.1.1.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
9.5.1.2.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
9.5.1.2.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
9.5.1.3.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
9.5.1.3.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
9.5.1.4.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
9.5.1.4.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
9.5.1.5.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
9.5.1.5.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
9.5.1.6.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
9.5.1.6.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)

10. Asia Pacific RNA Therapy Clinical Trials Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
10.3. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
10.4. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.5.RNA Therapy Clinical Trials Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
10.5.1.1.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
10.5.1.1.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
10.5.1.2.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
10.5.1.2.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
10.5.1.3.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
10.5.1.3.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
10.5.1.4.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
10.5.1.4.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
10.5.1.5.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
10.5.1.5.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
10.5.1.6.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
10.5.1.6.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)

11. Latin America RNA Therapy Clinical Trials Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
11.3. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
11.4. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
11.5.RNA Therapy Clinical Trials Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
11.5.1.1.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
11.5.1.1.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
11.5.1.2.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
11.5.1.2.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
11.5.1.3.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
11.5.1.3.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)

12. Middle East and Africa RNA Therapy Clinical Trials Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
12.3. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
12.4. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
12.5.RNA Therapy Clinical Trials Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
12.5.1.1.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
12.5.1.1.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
12.5.1.2.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
12.5.1.2.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. RNA Therapy Clinical Trials Market: By Modality, 2022-2032, USD (Million)
12.5.1.3.2. RNA Therapy Clinical Trials Market: By Clinical Trials Phase, 2022-2032, USD (Million)
12.5.1.3.3. RNA Therapy Clinical Trials Market: By Therapeutic Areas, 2022-2032, USD (Million)

13. Company Profile
13.1. Moderna Therapeutics
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. BioNTech SE
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Arrowhead Pharmaceuticals
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Alnylam Pharmaceuticals
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Ionis Pharmaceuticals
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Other Notable Players
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives